Inicio › Cáncer (todos los tipos) › Tennessee
Ensayos clínicos de Cáncer (todos los tipos) en Tennessee
91 estudios sobre Cáncer (todos los tipos) buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Regional One Health, Memphis
- Sarah Cannon Research Institute, Nashville
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 13 nov 2026 · NCT05920356Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07672769Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- The West Clinic, PC dba West Cancer Center, Germantown
Reclutando
Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07629206A Study of YL242 in Subjects With Advanced Solid Tumors
- US-205, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07197827Childhood Cancer Predisposition Study (CCPS)
- St. Jude Children's Research Hospital, Memphis
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 12 nov 2026 · NCT04511806A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Vanderbilt Ingram Cancer Center /ID# 252470, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Alliance for Multispecialty Research Clinical, Knoxville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Vanderbilt-Ingram Cancer Center at Franklin, Franklin
- Vanderbilt-Ingram Cancer Center Cool Springs, Franklin
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314Pan Tumor Rollover Study
- Tennesse Oncology, Nashville
- Local Institution - 0066, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT03899155Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- University of Tennessee Health Science Center, Knoxville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- SCRI Oncology Partners - PPDS, Nashville
ReclutandoFase 1
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07540572A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- The University of Tennessee Medical Center, Knoxville
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06901531A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Sarah Cannon Cancer Institute, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Tennessee Oncology Chattanooga, Chattanooga
- University of Tennessee Medical Center, Knoxville
- Baptist Memorial Hospital-Memphis, Memphis
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581A Study of JNJ-87890387 for Advanced Solid Tumors
- Sarah Cannon Research Institute, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06178614Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Sarah Cannon Research Inst, Nashville
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 nov 2026 · NCT03435796Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville
ReclutandoFase 3
Edades de 18 a 71 · Todos los sexos · Actualizado el 30 oct 2026 · NCT07504458Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- SCRI Oncology Partners, Nashville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07566156A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06835569Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Vanderbilt University Medical Center, Nashville
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT04981119Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 2
Edades de 2 a 99 · Todos los sexos · Actualizado el 21 oct 2026 · NCT05783323Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- SCRI Oncology Partners ( Site 7000), Nashville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT07405164A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Nashville
ReclutandoFase 3
Edades de 18 a 130 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07647328Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Baptist Medical Center, Memphis
- Tennessee Oncology, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221Galleri® in the Medicare Population.
- HCA Healthcare Brentwood, Brentwood
- HCA Healthcare Centennial, Nashville
- HCA Healthcare Nashville, Nashville
ReclutandoSe aceptan voluntarios sanos
Edades de 50 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT05673018Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT07493447A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Henry-Joyce Cancer Clinic, Nashville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- Vanderbilt University Medical Center, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT05382559A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- SCRI Oncology Partners /ID# 274522, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT07023289Suprachoroidal Administration in Subjects With Metastases to the Choroid
- Tennessee Retina, PC, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT06643884FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road /ID# 277891, Knoxville
- SCRI Oncology Partners /ID# 276959, Nashville
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07155187A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- SCRI Oncology Partners /ID# 279733, Nashville
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2026 · NCT07024784A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Vanderbilt University Medical Center, Nashville
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- Tennessee Oncology Proton Center, Franklin
- Thompson Proton Center, Knoxville
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 29 sept 2026 · NCT01255748A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
- SCRI Oncology Partners, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07612176A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- GSK Investigational Site, Nashville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07277270A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Tennessee Cancer Specialists - Knoxville - Old Weisgarber Road /ID# 280619, Knoxville
- University Of Tennessee Medical Center /ID# 279896, Knoxville
- Baptist Memorial Hospital /ID# 281405, Memphis
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT02693535De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.